BLABBERMOUTH.NET

FOO FIGHTERS have postponed their July 17 concert in Los Angeles after a member of the band's organization tested positive for COVID-19, the disease caused by the novel coronavirus. Earlier today, FOO FIGHTERS released the following statement: "Despite having made every effort to follow CDC Covid protocols and local laws, there has been a confirmed Covid-19 case within the FOO FIGHTERS organization. "Out of an abundance of caution and concern for the safety of the band, crew and most of all the fans, Saturdays show at the Los Angeles Forum is being postponed to a later date. The new date will be announced shortly. Tickets for the July 17th date will be honored for the new date." FOO FIGHTERS' concert at the Forum was supposed to mark the first full-capacity show at the iconic venue in more than a year. The band played a sold-out show on June 20 at the Madison Square Garden in New York City. To warm up for the MSG gig, FOO FIGHTERS performed five days earlier at the Canyon Club in Agoura Hills, California. Both venues required ticket buyers to be fully vaccinated against COVID-19 to attend. Last November, FOO FIGHTERS played a livestreamed concert for fans at The Roxy in West Hollywood, California. Six months later, they participated in the televised Live Vax concert at SoFi Stadium in Inglewood. FOO FIGHTERS are continuing to promote their latest album, "Medicine At Midnight", which landed at No. 1 on Billboard's Top Album Sales chart with first-week sales of 64,000 copies in the U.S. FOO FIGHTERS previously topped the chart with 2017's "Concrete And Gold" and 2011's "Wasting Light". 23,000 of "Medicine At Midnight"'s first-week sales came from vinyl LP sales, with CDs and digital albums registering 20,000 each. "Medicine At Midnight" came out on February 5 via Roswell Records/RCA Records. The LP is a nine-song, 37-minute effort which was produced by the FOO FIGHTERS and Greg Kurstin.
0 Comments

Leave a reply

Your email address will not be published. Required fields are marked *

*

 © amin abedi 

CONTACT US

Sending

Log in with your credentials

Forgot your details?